GOLDMAN SACHS GROUP INC - CELATOR PHARMACEUTICALS INC ownership

CELATOR PHARMACEUTICALS INC's ticker is CPXX and the CUSIP is 15089R102. A total of 20 filers reported holding CELATOR PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CELATOR PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$9,768,000
+1033.2%
323,663
+314.0%
0.00%
Q1 2016$862,000
+1386.2%
78,182
+124.7%
0.00%
Q3 2015$58,000
+100.0%
34,795
+201.3%
0.00%
Q1 2015$29,00011,5500.00%
Other shareholders
CELATOR PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
CAXTON CORP 2,246,469$3,729,0005.03%
TFS CAPITAL LLC 22,443$37,0000.00%
UBS Group AG 500$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 67,015$111,0000.00%
Tower Research Capital LLC (TRC) 25$00.00%
CITIGROUP INC 135$00.00%
NORTHERN TRUST CORP 20,724$35,0000.00%
GOLDMAN SACHS GROUP INC 34,795$58,0000.00%
WELLS FARGO & COMPANY/MN 2,200$4,0000.00%
MORGAN STANLEY 456$1,0000.00%
View complete list of CELATOR PHARMACEUTICALS INC shareholders